Search Results - "Borton, Mary Ann"

963 Influence of PPI Run-in, pH Monitoring and Nutrient Tolerance On Efficacy Outcomes of Acotiamide Hydrochloride (YM443), a Novel Acetylcholine Esterase Inhibitor, in Functional Dyspepsia by Tack, Jan F, Talley, Nicholas J, Kowalski, Donna L, Borton, Mary Ann, Barve, Abhijit

Get full text

1053 A Novel Acetylcholine Esterase Inhibitor Acotiamide Hydrochloride (YM443) in Functional Dyspepsia: Efficacy in a Randomized, Double-Blind, Placebo-Controlled Dose Ranging Trial by Talley, Nicholas J, Tack, Jan F, Kowalski, Donna L, Borton, Mary Ann, Barve, Abhijit

Get full text

Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience by Yocum, D. E., Furst, D. E., Bensen, W. G., Burch, F. X., Borton, M. A., Mengle-Gaw, L. J., Schwartz, B. D., Wisememandle, W., Mekki, Q. A.

“…Objective. To evaluate the long-term safety of tacrolimus 3 mg/day in patients with rheumatoid arthritis (RA). Methods. Patients with active RA who had…”
Get full text

Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate by Kremer, Joel M., Habros, Joseph S., Kolba, Karen S., Kaine, Jeffrey L., Borton, Mary Ann, Mengle‐Gaw, Laurel J., Schwartz, Benjamin D., Wisemandle, Wayne, Mekki, for the Tacrolimus‐Methotrexate Rheumatoid Arthritis Study Group, Qais A.

“…Objective To assess the safety of tacrolimus used in combination with oral methotrexate (MTX) to control the signs and symptoms of rheumatoid arthritis (RA) in…”
Get full text

Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: A double‐blind trial by Yocum, David E., Furst, Daniel E., Kaine, Jeffrey L., Baldassare, Andrew R., Stevenson, Jon T., Borton, Mary Ann, Mengle‐Gaw, Laurel J., Schwartz, Benjamin D., Wisemandle, Wayne, Mekki, Qais A.

“…Objective To evaluate the efficacy and safety of tacrolimus as monotherapy in controlling the signs and symptoms of patients with rheumatoid arthritis (RA)…”
Get full text

Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: A six-month, open-label study by KREMER, Joel M, HABROS, Joseph S, KOLBA, Karen S, KAINE, Jeffrey L, BORTON, Mary Ann, MENGLE-GAW, Laurel J, SCHWARTZ, Benjamin D, WISEMANDLE, Wayne, MEKKI, Qais A

“…To assess the safety of tacrolimus used in combination with oral methotrexate (MTX) to control the signs and symptoms of rheumatoid arthritis (RA) in patients…”
Get full text

Reply by Yocum, David E., Furst, Daniel E., Kaine, Jeffrey L., Baldassare, Andrew, Stevenson, Jon T., Borton, Mary Ann, Wisemandle, Wayne, Mekki, Qais A., Mengle‐Gaw, Laurel J., Schwartz, Benjamin D.

Get full text

Reply by Yocum, David E., Furst, Daniel E., Kaine, Jeffrey L., Baldassare, Andrew, Stevenson, Jon T., Borton, Mary Ann, Wisemandle, Wayne, Mekki, Qais A., Mengle‐Gaw, Laurel J., Schwartz, Benjamin D.

Get full text

Failure to report previously used drugs and dosages in pharmaceutical company–sponsored rheumatoid arthritis trials: Comment on the article by Yocum et al by Parker, Christopher T., Rennie, Thomas

Get full text